PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Sep-2025 Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration Sanofi
11-Sep-2025 PharmaSGP publishes preliminary half-year figures for 2025 PharmaSGP Holding SE
10-Sep-2025 Medical Affairs Summit 2025: Shaping the Future of Healthcare Innovation Marcus Evans
10-Sep-2025 Building for the Future: Why Eramol is Investing in a New Sterile Manufacturing Facility Eramol
10-Sep-2025 Bioversys reports corporate highlights and key financials for the first half 2025 BioVersys AG
10-Sep-2025 Launch of Galenica Diagnostics: Acquisition of Labor Team completed Galenica AG
09-Sep-2025 Lundbeck sharpens commercial focus in line with strategy, initiates partnering in 27 markets by end-2025 Lundbeck
09-Sep-2025 aap successfully completes human clinical trial for antibacterial surface technology aap Implantate AG
09-Sep-2025 Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder Servier
09-Sep-2025 Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis Immunic AG
09-Sep-2025 Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47% Eckert & Ziegler SE
09-Sep-2025 M1 Kliniken AG: Successful First Half of 2025 with EBIT Growth of 24% and Earnings per Share of EUR 0.63 M1 Kliniken AG
08-Sep-2025 Abivax Presents First Half 2025 Financial Results ABIVAX
08-Sep-2025 Stanford University Secures NIH Grant to Advance tiakis Biotech´s Elafin (Tiprelestat) Through a U.S. Phase II Trial in Pulmonary Arterial Hypertension tiakis Biotech AG
08-Sep-2025 AEVIS VICTORIA SA – Strong growth in revenue and consolidated results in the first half of 2025 AEVIS VICTORIA SA
08-Sep-2025 Medacta Group SA reports surge in adjusted EBITDA margin to 29.6% in constant currency in H1 2025 Medacta Group SA
05-Sep-2025 bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments bonyf NV
05-Sep-2025 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
05-Sep-2025 Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues Curatis Holding AG
05-Sep-2025 Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP) Newron Pharmaceuticals S.p.A.